CAUSEY CHRISTOPHER 4
4 · UNITED THERAPEUTICS Corp · Filed Feb 25, 2026
Insider Transaction Report
Form 4
CAUSEY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-25$119.76/sh+1,000$119,760→ 5,190 total - Sale
Common Stock
[F1]2026-02-25$520.00/sh−1,000$520,000→ 4,190 total - Exercise/Conversion
Stock Option
[F1]2026-02-25−1,000→ 6,320 totalExercise: $119.76From: 2021-06-26Exp: 2030-06-26→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-02-25